• Events
  • news
    • Press releases
    • Blog
    • Media Coverage
  • Documents
  • About
  • Team
  • funds
    • o2h Seven Sisters EIS Growth
    • o2h Seven Sisters KI EIS Growth
    • o2h human health KI EIS
    • o2h human health SEIS
    • o2h human health EIS
  • Portfolio
  • knowledgehub
    • Science in Focus – Atelerix
    • What is Knowledge Intensive EIS fund ?
  • Contact

o2h-ventures

  • Events
  • news
    • Press releases
    • Blog
    • Media Coverage
  • Documents
  • About
  • Team
  • funds
    • o2h Seven Sisters EIS Growth
    • o2h Seven Sisters KI EIS Growth
    • o2h human health KI EIS
    • o2h human health SEIS
    • o2h human health EIS
  • Portfolio
  • knowledgehub
    • Science in Focus – Atelerix
    • What is Knowledge Intensive EIS fund ?
  • Contact

Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more

o2h ChaiTime – Korea 2026

Join us in Seoul for o2h ChaiTime Korea 2026 and be part of the conversation connecting biotech, investment and innovation.

About the event

Join us for a special edition of o2h ChaiTime as we take our discussion-led life sciences forum global, bringing together the biotech and investment community in Seoul, South Korea.

​Hosted at Aston Hall, British Embassy Seoul, this invitation-only gathering will bring together a curated audience of biotech founders, investors, pharmaceutical leaders, business development teams and strategic partners from Korea, the UK and the wider international life sciences ecosystem.

​Taking place on the Friday ahead of BioJapan, the event offers an opportunity to explore the ideas, science and investment opportunities shaping the next chapter of biotech, while connecting with leading investors, innovators and industry decision-makers from across the region and beyond.

​The afternoon will feature thought-provoking discussions, a panel conversation and presentations from selected o2h Ventures portfolio companies, followed by an informal networking reception. The programme will explore themes ranging from the next major opportunities in biotech and the changing investment landscape to AI-enabled drug discovery and the evolution of global biotech partnerships.

​Agenda

  • ​2:00 PM – 2:15 PM | Arrival & Networking
  • ​2:15 PM – 2:25 PM | Welcome Remarks by FCDO & o2h Ventures
  • ​2:25 PM – 2:40 PM | Keynote Address
  • ​2:40 PM – 3:10 PM | Panel Discussion – Biotech Right Now: What’s Moving the Needle?
  • ​3:10 PM – 4:00 PM | Biotech Portfolio Showcase
  • Atelerix
  • Spirea
  • Heartfelt
  • ​4:00 PM – 5:00 PM | Networking Reception


  • ​Please note: Attendance is by invitation only and registrations will initially be placed on a waitlist due to limited capacity. Confirmed attendees will be notified separately.
o2h-ventures
02-10-2026
o2h-ventures
2:00 PM - 5:00 PM GMT
o2h-ventures
British Embassy, Seoul, South Korea
Register now

Share with your friends

Related events

events category

Biotech Bikers - Aug 2026

Event Image
attending in-person organising
calendar-icon 22nd August, 2026

Biotech Bikers - Cambridge Aug 2026

Biotech Bikers brings together investors, founders, and scientists for cycling, networking and idea exchange within the life sciences ecosystem.
Discover more
events category

CWOW Edition

Event Image
calendar-icon 15th June, 2026

o2h ChaiTime - Biotech Now & Next

o2h ChaiTime: Biotech Now & Next, in collaboration with Cambridge Wide Open Week, focused on biotech trends, innovation, and networking.
Discover more
events category

Biotech Bikers - Jun 2026

Event Image
attending in-person organising
calendar-icon 13th June, 2026

Biotech Bikers - Cambridge Jun 2026

Biotech Bikers brings together investors, founders, and scientists for cycling, networking, and idea exchange within the life sciences ecosystem.
Discover more
o2h-ventures

contact us

o2h Ventures Limited
Hauxton House,
The Mill SciTech Park,
Mill Lane, Hauxton
Cambridge
CB22 5HX
07341612481
invest@o2h.com
about
  • about us
  • team
  • portfolio
  • funds
insights and news
  • knowledge hub
  • press releases
  • blog
  • events
  • documents
connect with us
  • linkedin
  • youtube
  • email
Please refer to the relevant fund’s full risk warnings contained in their Information Memorandums.
Your capital is at risk. Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. o2h Ventures’ funds are targeted exclusively at sophisticated or high net worth investors who understand these risks and make their own investment decisions. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.
o2h Ventures Limited is regulated and authorised by the Financial Conduct Authority (FRN 812245). Capital at risk, only suitable for high net worth and sophisticated investors.
© 2026 o2h ventures
  • Privacy Policy
  • Blog
  • Contact us

Risk Information

Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk

What are the key risks?

1 – You could lose all the money you invest

• If the business you invest in fails, you are likely to lose 100% of the money you invest. Most start-up businesses fail.

2 – You are unlikely to be protected if something goes wrong

• Protection from the Financial Services Compensation Scheme (FSCS), in relation to claims against failed regulated firms, does not cover poor investment performance. Try the FSCS investment protection checker here. (https://www.fscs.org.uk/check/investment-protection-checker)

• Protection from the Financial Ombudsman Service (FOS) does not cover poor investment performance. If you have a complaint against an FCA-regulated firm, FOS may be able to consider it. Learn more about FOS protection here. (https://www.financial-ombudsman.org.uk/consumers)

3 – You won’t get your money back quickly

• Even if the business you invest in is successful, it may take several years to get your money back. You are unlikely to be able to sell your investment early.

• The most likely way to get your money back is if the business is bought by another business or lists its shares on an exchange such as the London Stock Exchange. These events are not common.

• If you are investing in a start-up business, you should not expect to get your money back through dividends. Start-up businesses rarely pay these.

4 – Don’t put all your eggs in one basket

• Putting all your money into a single business or type of investment for example, is risky. Spreading your money across different investments makes you less dependent on any one to do well.

• A good rule of thumb is not to invest more than 10% of your money in high-risk investments (https://www.fca.org.uk/investsmart/5-questions-ask-you-invest)

5 – The value of your investment can be reduced

• The percentage of the business that you own will decrease if the business issues more shares. This could mean that the value of your investment reduces, depending on how much the business grows. Most start-up businesses issue multiple rounds of shares.

• These new shares could have addition rights that your shares don’t have, such as the right to receive a fixed dividend, which could further reduce your chances of getting a return on your investment.

If you are interested in learning more about how to protect yourself, visit the FCA’s website here (https://www.fca.org.uk/investsmart)